My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    Summaires for patients. In some women, postmenopausal hormone use increases short-term risk for heart disease, but decreases risk in the long term.

    [No authors listed]

    Ann Intern Med. 2001 Jul 3;135(1):S17. No abstract available. PMID: 11462993 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hormone replacement therapy in postmenopausal women with heart disease and risk for gallstones that require surgery.

    [No authors listed]

    Ann Intern Med. 2001 Oct 2;135(7):S-44. No abstract available. PMID: 11596574 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.

    Simon JA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Pickar JH.

    Ann Intern Med. 2001 Oct 2;135(7):493-501.PMID: 11578152 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Do statins and hormonal replacement therapy in combination reduce cardiovascular risk in postmenopausal women?

    Rosolova H.

    Eur Heart J. 2000 Feb;21(3):178-80. No abstract available. PMID: 10639296 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hormone replacement therapy and coronary heart disease: results of randomized trials.

    Petitti D.

    Prog Cardiovasc Dis. 2003 Nov-Dec;46(3):231-8. Review.PMID: 14685941 [PubMed - indexed for MEDLINE]Related articles

    6.

    Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.

    Mohandas B, Mehta JL.

    Curr Opin Cardiol. 2007 Sep;22(5):434-42.PMID: 17762545 [PubMed - indexed for MEDLINE]Related articles

    7.

    The changing view of hormone replacement therapy.

    Vogel RA.

    Rev Cardiovasc Med. 2003 Spring;4(2):68-71. Review.PMID: 12776015 [PubMed - indexed for MEDLINE]Related articles

    8.

    Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease.

    McCubbin JA, Helfer SG, Switzer FS 3rd, Price TM.

    Am Heart J. 2002 Apr;143(4):711-7.PMID: 11923810 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.

    Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E.

    Am J Med. 2002 Nov;113(7):543-8.PMID: 12459399 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lipid metabolism, physical activity, and postmenopausal hormone therapy.

    Wenger NK.

    Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S80-8. Review.PMID: 9820467 [PubMed - indexed for MEDLINE]Related articles

    11.

    Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women.

    Beral V, Reeves G, Banks E.

    BJOG. 2005 Jun;112(6):692-5. Review. No abstract available. PMID: 15924521 [PubMed - indexed for MEDLINE]Related articles

    12.

    Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration.

    Campisi R, Nathan L, Pampaloni MH, Schöder H, Sayre JW, Chaudhuri G, Schelbert HR.

    Circulation. 2002 Jan 29;105(4):425-30.PMID: 11815423 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevention of coronary heart disease in post-menopausal women.

    Cullen P, von Eckardstein A, Barrett-Connor E, Lewis B, Mancini M, Riesen W, Schober O, Fruchart JC, Schwandt P, Assmann G; International Task Force for Prevention of Coronary Heart Disease.

    Nutr Metab Cardiovasc Dis. 2000 Oct;10(5):267-74. Review. No abstract available. PMID: 11213536 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.

    Windler E, Zyriax BC, Eidenmüller B, Boeing H.

    Maturitas. 2007 Jul 20;57(3):239-46. Epub 2007 Feb 9.PMID: 17292571 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.

    Lacut K, Oger E, Abalain JH, Moineau MP, Mottier D; SARAH Investigators.

    Atherosclerosis. 2004 May;174(1):173-80.PMID: 15135267 [PubMed - indexed for MEDLINE]Related articles

    16.

    Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy.

    Grodstein F, Manson JE, Stampfer MJ, Rexrode K.

    Arch Intern Med. 2008 Apr 28;168(8):861-6.PMID: 18443262 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):49-57. Erratum in: JAMA 2002 Sep 4;288(9):1064. PMID: 12090862 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

    Dumeaux V, Fournier A, Lund E, Clavel-Chapelon F.

    Cancer Causes Control. 2005 Jun;16(5):537-44.PMID: 15986108 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy.

    Heckbert SR, Kaplan RC, Weiss NS, Psaty BM, Lin D, Furberg CD, Starr JR, Anderson GD, LaCroix AZ.

    Arch Intern Med. 2001 Jul 23;161(14):1709-13.PMID: 11485503 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study.

    Liu B, Beral V, Balkwill A, Green J, Sweetland S, Reeves G; Million Women Study Collaborators.

    BMJ. 2008 Jul 10;337:a386. doi: 10.1136/bmj.a386.PMID: 18617493 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity